article thumbnail

Mankind Pharma IPO Review 2023 – Financials, Competitors & More

Trade Brains

Mankind Pharma IPO Review 2023 – About The Company Established in 1991, Mankind Pharma Limited is a pharmaceutical company engaged in the business of developing, manufacturing, and marketing a diverse range of pharmaceutical formulations covering acute and chronic therapeutic areas along with several consumer healthcare products.

article thumbnail

Fundamental Analysis Of Sun Pharma – Financials & More Details

Trade Brains

Company Overview Sun Pharmaceutical Industries Ltd. Over the last 40 years, it has become the largest pharma company in India and the fourth-largest speciality generic pharmaceutical company in the world with a market capitalisation of Rs 2,25,000 crore. A highlight of the future plans and a summary conclude the article at the end.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cipla Vs Dr. Reddy’s Laboratories – Financials, Future Plans & More

Trade Brains

According to the Economic Survey 2023, India’s domestic pharmaceutical market was estimated at $41 billion. The roots of India’s pharmaceutical capabilities lay deep within its rich history. It is the 3 rd largest pharmaceutical company in India as well as the private pharmaceutical market of South Africa.

article thumbnail

21 High Paying Medical Jobs Without A Degree To Explore

Clever Girl Finance

If you want to be a paramedic, then training, passing exams, and getting licensed as a paramedic is required. Licensed practical nurse (LPN) Median salary for licensed practical nurses: $54,620 a year Licensed practical nurses (LPNs) work under the supervision of registered nurses or physicians to provide direct patient care.

Medical 96
article thumbnail

Paragon Fine and Speciality Chemicals IPO Review – GMP & More

Trade Brains

Industry Overview The Indian chemical industry is a global leader in exports and imports of chemicals, excluding pharmaceuticals. The Indian chemical industry is largely de-licensed, except for a few hazardous chemicals. It ranks 14th in exports and 8th in imports worldwide. The market is expected to grow at 9.3%

article thumbnail

: Regeneron’s high-dose Eylea not approved by FDA

MarketWatch

Regeneron Pharmaceuticals Inc. Food and Drug Administration issued a complete response letter for the biologics license application for a higher-dose version of Eylea for treatment of wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. REGN said Tuesday that the U.S.

article thumbnail

Yatharth Hospital IPO Review – GMP, Price, Date & Financials

Trade Brains

2) The business may get affected if it is unable to secure or renew the approvals, licenses, registrations, and permits we need to run promptly, or even at all. The ROE and RoCE of the company for FY23 stood at 35.95% and 26.10% respectively. The company also deals with high fixed costs that can also impact its profitability.